Acquiring Company
Aurinia Pharma
Acquired Company
Kezar Life Sciences
Bilbao
CaliforniaBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaBiotechnologyHealth CareTherapeuticsBiopharmaDescription
Aurinia Pharmaceuticals has entered a definitive merger agreement to acquire Kezar Life Sciences for $6.955 per share plus contingent value rights. The transaction is designed to offer liquidity to Kezar's shareholders and further develop Kezar's lead product, zetomipzomib. Aurinia's acquisition is expected to close in the second quarter of 2026, following a tender offer commencing by April 13, 2026.
Who to call at Aurinia Pharma, and when
When Aurinia Pharma changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Aurinia Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aurinia Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aurinia Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aurinia Pharma makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Kezar Life Sciences?
Kezar Life Sciences was acquired by Aurinia Pharma, based in Bilbao. The deal was reported on March 30, 2026. Aurinia Pharma is a biopharmaceutical company focused on developing and commercializing therapeutics to treat kidney diseases. The company is dedicated to advancing innovative solutions to improve patients' lives. Aurinia Pharma is publicly traded (AUPH) and operates in Biotechnology.
When did Aurinia Pharma acquire Kezar Life Sciences?
Aurinia Pharma's acquisition of Kezar Life Sciences was reported on March 30, 2026. Aurinia Pharmaceuticals has entered a definitive merger agreement to acquire Kezar Life Sciences for $6.955 per share plus contingent value rights. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Kezar Life Sciences do?
Kezar Life Sciences is a clinical-stage biopharmaceutical company discovering and developing novel treatments for immune-mediated and oncologic disorders. It is privately held, operating in Biotechnology, and is based in California.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.